IP Library › Patent Application 13545029
Patent Application
App. No. 13/545,029

Chemical Compounds

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/545,029
Abstract

Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.

Claims (2)

1 - 10 . (canceled)

11 . A pharmaceutical composition comprising 1) a compound which is an inhibitor of erb-B2 and 2) a HCl salt of the compound

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2016
From: GLAXOSMITHKLINE
To: LEO OSPREY LIMITED
Reel/Frame 039249/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2016
From: LEO OSPREY LIMITED
To: NOVARTIS AG
Reel/Frame 039249/0837 →